4329.0 - Characteristics of people using mental health services and prescription medication, 2011  
ARCHIVED ISSUE Released at 11:30 AM (CANBERRA TIME) 28/10/2014  First Issue
   Page tools: Print Print Page Print all pages in this productPrint All

Appendix B - PBS Items


PBS subsidised mental health-related prescription medication
CodeMedication groupsCodeMedication subgroup
N05Psycholeptics
N05AAntipsychoticsN05AA Phenothiazines with aliphatic side-chain
N05ABPhenothiazines with piperazine structure
N05ACPhenothiazines with piperidine structure
N05ADButyrophenone derivatives
N05AEIndole derivatives
N05AF Thioxanthene derivatives
N05AH Diazepines, oxazepines, thiazepines and oxepines
N05AL Benzamides
N05AXOther antipsychotics
N05BAnxiolyticsN05BABenzodiazepine derivatives
N05CHypnotics and Sedatives N05CDBenzodiazepine derivatives
N06Psychoanaleptics
N06AAntidepressantsN06AANon-selective monoamine reuptake inhibitors
N06ABSelective serotonin reuptake inhibitors
N06AFMonoamine oxidase inhibitors, non-selective
N06AGMonoamine oxidase A inhibitors
N06AXOther antidepressants
N06BPsychostimulants, agents used for ADHD and NootopicsN06BACentrally acting sympathomimetics


Descriptions of Medications

N05 PsycholepticsA group of drugs that tranquillises (central nervous system depressants)
Antipsychotics (N05A)Drugs used to treat symptoms of psychosis (a severe mental disorder characterised by loss of contact with reality, delusions and hallucinations), common in conditions such as schizophrenia, mania and delusional disorder.
Anxiolytics (N05B)Drugs prescribed to treat symptoms of anxiety.
Hypnotics and sedatives (N05C)Hypnotic drugs are used to induce sleep and treat severe insomnia.
Sedative drugs are prescribed to reduce excitability or anxiety.
N06 PsychoanalepticsA group of drugs that stimulates the mood (central nervous system stimulants)
Antidepressants (N06A)Drugs used to treat the symptoms of clinical depression.
Psychostimulants and nootropics (N06B)Agents used for attention-deficit hyperactivity disorder and to improve impaired cognitive abilities (nootropics).


Source: Australian Institute of Health and Welfare, 2014, 'Medicare-subsidised mental health-related prescriptions', viewed 13 August 2014, < https://mhsa.aihw.gov.au/services/medicare/>